Clinical Trials
4 trialsNCT05053308 2023-08-07
Proportional Dose of Sublingual Fentanyl Tablet Based on Daily Opioid Requirement
Seoul National University
Phase NA Withdrawn
NCT03809455 2020-04-22
FARADI
UNICANCER
Phase 2 Withdrawn
NCT02869321 2019-05-13
ANTALGIP
Central Hospital, Nancy, France
Phase 4 Completed
NCT00125294 2017-09-25
Sublingual Methadone for the Management of Cancer Breakthrough Pain
AHS Cancer Control Alberta
Phase 1 Completed